ENZON PHARMACEUTICALS INC
ENZN
ENZN was delisted on the 19th of May, 2016.
82 hedge funds and large institutions have $57.1M invested in ENZON PHARMACEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 6 closing their positions.
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
3% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 31
1% less funds holding
Funds holding: 83 → 82 (-1)
19% less capital invested
Capital invested by funds: $70.2M → $57.1M (-$13.1M)
83% less call options, than puts
Call options by funds: $4K | Put options by funds: $24K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$342K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$319K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$291K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$231K |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
+$219K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Gruss Capital Management
New York
|
-$1.03M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$614K |
| 3 |
ARC
Absolute Return Capital
Boston,
Massachusetts
|
-$425K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$294K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$278K |
ENZN Hedge Fund Activity: Q3 2013 in Review
82 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q3 2013, worth a combined $57.1M — down 19% from $70.2M a quarter earlier.
Fund positioning in ENZN was balanced in Q3 2013: 6 funds opened new positions, 6 closed out, 30 added to existing stakes and 31 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $342K. The largest seller was Gruss Capital Management, exiting entirely with an estimated $1.03M sold.
- 82 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q3 2013, down from 83 in Q2 2013.
- Funds reported $57.1M of ENZON PHARMACEUTICALS INC stock for Q3 2013, down 19% quarter-over-quarter.
- 6 funds opened new ENZON PHARMACEUTICALS INC positions in Q3 2013 and 6 closed out, a net change of 0 holders.
- The largest ENZON PHARMACEUTICALS INC buyer in Q3 2013 was BlackRock Fund Advisors, an estimated $342K added.
- The largest ENZON PHARMACEUTICALS INC seller in Q3 2013 was Gruss Capital Management, an estimated $1.03M sold.
Based on aggregated 13F filings for Q3 2013.